It is important that diagnosed individuals are also reviewed by endocrinologists so that weight loss therapies, insulin sensitizers, and other glucose-lowering agents can be started at a young age to limit the impact of poor glycemic control and prevent the complications of accelerated metabolic disease. Here, INS is linked to metabolic disease.